* hypersensitivity to chloroquine or hydroxychloroquine * those who are contraindicated in hydroxychloroquine administration according to the permission requirements such as pregnant women, nursing mothers, visual disorders, macular disease, and porphyria, etc. * human immunodeficiency virus (hiv) infected person * patients with autoimmune disease (systemic lupus erythematosus, mixed connective tissue disease) * patients with autoimmune rheumatoid inflammatory disease (aiird; autoimmune inflammatory rheumatic diseases - ankylosing spondylitis, rheumatic arthritis, psoriatic arthritis) * arrhythmia, liver cirrhosis of child pugh c, chronic renal failure with egfr≤30ml / min / 1.73m2 * a person who is positive in the covid-19 screening pcr test before starting pep

* hypersensitivity to chloroquine or hydroxychloroquine * those who are contraindicated in hydroxychloroquine administration according to the permission requirements such as pregnant women, nursing mothers, visual disorders, macular disease, and porphyria, etc. * human immunodeficiency virus (hiv) infected person * patients with autoimmune disease (systemic lupus erythematosus, mixed connective tissue disease) * patients with autoimmune rheumatoid inflammatory disease (aiird; autoimmune inflammatory rheumatic diseases - ankylosing spondylitis, rheumatic arthritis, psoriatic arthritis) * arrhythmia, liver cirrhosis of child pugh c, chronic renal failure with egfr≤30ml / min / 1.73m2 * a person who is positive in the covid-19 screening pcr test before starting pep

- hypersensitivity to chloroquine or hydroxychloroquine - those who are contraindicated in hydroxychloroquine administration according to the permission requirements such as pregnant women, nursing mothers, visual disorders, macular disease, and porphyria, etc. - human immunodeficiency virus (hiv) infected person - patients with autoimmune disease (systemic lupus erythematosus, mixed connective tissue disease) - patients with autoimmune rheumatoid inflammatory disease (aiird; autoimmune inflammatory rheumatic diseases - ankylosing spondylitis, rheumatic arthritis, psoriatic arthritis) - arrhythmia, liver cirrhosis of child pugh c, chronic renal failure with egfr≤30ml / min / 1.73m2 - a person who is positive in the covid-19 screening pcr test before starting pep

- hypersensitivity to chloroquine or hydroxychloroquine - those who are contraindicated in hydroxychloroquine administration according to the permission requirements such as pregnant women, nursing mothers, visual disorders, macular disease, and porphyria, etc. - human immunodeficiency virus (hiv) infected person - patients with autoimmune disease (systemic lupus erythematosus, mixed connective tissue disease) - patients with autoimmune rheumatoid inflammatory disease (aiird; autoimmune inflammatory rheumatic diseases - ankylosing spondylitis, rheumatic arthritis, psoriatic arthritis) - arrhythmia, liver cirrhosis of child pugh c, chronic renal failure with egfr≤30ml / min / 1.73m2 - a person who is positive in the covid-19 screening pcr test before starting pep